Current and Future Pharmacologic Treatment of Sarcopenia

• Autores: Yves Rolland, Graziano Onder, John E. Morley, Sophie Gillette Guyonet, Gabor Abellan van Kan, Bruno Vellas
• Localización: Clinics in geriatric medicine, ISSN 0749-0690, Vol. 27, Nº. 3, 2011, págs. 423-447
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Dialnet Métricas: 2 Citas
• Resumen

  • Sarcopenia is a complex multifactorial condition that can by treated with multimodal approaches. No pharmacologic agent to prevent or treat sarcopenia has been as efficacious as exercise (mainly resistance training) in combination with nutritional intervention (adequate protein and energy intake). However, performing resistance training sessions and following nutritional advice can be challenging, especially for frail, sarcopenic, elderly patients, and results remain only partial. Therefore, new pharmacologic agents may substantially reduce the functional decline in older people. This article reviews the new pharmacologic agents currently being assessed for treating sarcopenia.